4//SEC Filing
Clayman Michael D. 4
Accession 0001209191-21-022677
CIK 0001419600other
Filed
Mar 22, 8:00 PM ET
Accepted
Mar 23, 7:01 PM ET
Size
9.2 KB
Accession
0001209191-21-022677
Insider Transaction Report
Form 4
Clayman Michael D.
DirectorPresident and CEO
Transactions
- Gift
Common Stock
2021-02-01−21,099→ 347,140 total - Gift
Common Stock
2021-01-08−4,762→ 368,239 total
Holdings
- 24,600(indirect: By Trust)
Common Stock
- 373,769(indirect: By Trust)
Common Stock
- 388,683(indirect: By LLC)
Common Stock
Footnotes (3)
- [F1]On January 8, 2021, the Reporting Person transferred 4,762 shares of the Issuer's Common Stock to The Michael D.Clayman 2006 Revocable Trust.
- [F2]On February 1, 2021, the Reporting Person transferred 21,099 shares of the Issuer's Common Stock to The Michael D. Clayman 2006 Revocable Trust.
- [F3]Shares held by Versant Development Fund III, LLC. The Reporting Person is a manager and minority member of Versant Development Fund III, LLC. The Reporting Person disclaims any beneficial ownership of the shares held by Versant Development Fund III, LLC except to the extent of his pecuniary interest in these shares.
Documents
Issuer
Flexion Therapeutics Inc
CIK 0001419600
Entity typeother
Related Parties
1- filerCIK 0001597407
Filing Metadata
- Form type
- 4
- Filed
- Mar 22, 8:00 PM ET
- Accepted
- Mar 23, 7:01 PM ET
- Size
- 9.2 KB